{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T05:16:23Z","timestamp":1740287783428,"version":"3.37.3"},"reference-count":14,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n          <jats:title>Introduction<\/jats:title>\n          <jats:p>Catatonia is a syndrome characterized by psychomotor and behavioral disturbances and is associated with a substantially increased mortality risk in adolescent patients. There is a dearth of published literature describing treatment strategies for pediatric patients with catatonia. This dual-case series will describe the treatment course of 2 adolescent patients with catatonia at our pediatric inpatient psychiatric facility.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Case Series<\/jats:title>\n          <jats:p>This case series presents 2 adolescent patients (a 17-year-old male and a 16-year-old female) who initially presented with worsening agitation and paranoia, later developing catatonia. Both patients required long durations of hospitalization and were treated with high-dose lorazepam before requiring the addition of electroconvulsive therapy (ECT).<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Discussion<\/jats:title>\n          <jats:p>Treatment of pediatric patients with catatonia creates a significant burden on patients, families, and the healthcare system. Treatment with high-dose benzodiazepines is high risk, while ECT is both difficult to access and comes with its own risks. Both patients discussed are transitional age, meaning they will soon be young adults who will continue to require high-level psychiatric care. Psychiatric pharmacists have a large role to play in ensuring safe medication management for these complex patients.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Conclusions<\/jats:title>\n          <jats:p>This case series of 2 adolescent patients with catatonia demonstrates marginal reduction in symptoms with high-dose lorazepam in conjunction with ECT, with minimal side effects. This case series adds to the limited available literature regarding treatment of catatonia in pediatric patients and highlights the need for further study into effective treatment alternatives.<\/jats:p>\n        <\/jats:sec>","DOI":"10.9740\/mhc.2024.06.215","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:01:47Z","timestamp":1717372907000},"page":"215-219","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacologic management of adolescent catatonia: A dual-case series"],"prefix":"10.9740","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0349-2779","authenticated-orcid":true,"given":"Lauren","family":"Leiby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9002-4028","authenticated-orcid":true,"given":"Lauryn","family":"Shiplett","sequence":"additional","affiliation":[{"name":"Behavioral Health Patient Care Pharmacist, Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2898-3778","authenticated-orcid":true,"given":"Wendy","family":"Lin","sequence":"additional","affiliation":[{"name":"Behavioral Health Patient Care Pharmacist, Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2270-9018","authenticated-orcid":true,"given":"Matthew","family":"Dick","sequence":"additional","affiliation":[{"name":"Behavioral Health Patient Care Pharmacist, Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1738-4499","authenticated-orcid":true,"given":"Hannah","family":"Thornton","sequence":"additional","affiliation":[{"name":"Pharmacy Operations Manager, Behavioral Health & Perioperative Services, Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"key":"i2168-9709-14-3-215-b01","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Lu","year":"2013","unstructured":"Lu\n              FG,\n            \n            American Psychiatric Association.\n          \n          \n            Diagnostic and Statistical Manual of Mental Disorders\n          . 5th ed. Amer Psychiatric Pub Inc; 2013."},{"issue":"5","key":"i2168-9709-14-3-215-b02","series-title":"Pediatr Neurol","first-page":"307","article-title":"Catatonia is hidden in plain sight among different pediatric disorders: A review article","volume":"43","author":"Dhossche","year":"2010","unstructured":"Dhossche\n              DM,\n            \n            \n              Wachtel\n              LE.\n            \n          \n          Catatonia is hidden in plain sight among different pediatric disorders: A review article. Pediatr Neurol. 2010;43(5):307-15. DOI: 10.1016\/j.pediatrneurol.2010.07.001"},{"issue":"2-3","key":"i2168-9709-14-3-215-b03","series-title":"Schizophr Res","first-page":"233","article-title":"Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study","volume":"113","author":"Cornic","year":"2009","unstructured":"Cornic\n              F,\n            \n            \n              Consoli\n              A,\n            \n            \n              Tanguy\n              ML,\n            \n            \n              Bonnot\n              O,\n            \n            \n              P\u00e9risse\n              D,\n            \n            \n              Tordjman\n              S,\n            \n            et al.\n          \n          Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res. 2009;113(2-3):233-40. DOI: 10.1016\/j.schres.2009.04.021"},{"issue":"4","key":"i2168-9709-14-3-215-b04","series-title":"J Psychopharmacol","first-page":"327","article-title":"Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers","year":"2023","unstructured":"Rogers\n              JP,\n            \n            \n              Oldham\n              MA,\n            \n            \n              Fricchione\n              G,\n            \n            \n              Northoff\n              G,\n            \n            \n              Ellen Wilson\n              J,\n            \n            \n              Mann\n              SC,\n            \n            et al.\n          \n          Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023;37(4):327-69. DOI: 10.1177\/02698811231158232"},{"issue":"11","key":"i2168-9709-14-3-215-b05","series-title":"Arch Gen Psychiatry","first-page":"1173","article-title":"The catatonia syndrome: Forgotten but not gone","volume":"66","author":"Fink","year":"2009","unstructured":"Fink\n              M,\n            \n            \n              Taylor\n              MA.\n            \n          \n          The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry. 2009;66(11):1173-7. DOI: 10.1001\/archgenpsychiatry.2009.141"},{"issue":"2","key":"i2168-9709-14-3-215-b06","series-title":"Ann Clin Psychiatry","first-page":"97","article-title":"Catatonia: A review","volume":"20","author":"Weder","year":"2008","unstructured":"Weder\n              ND,\n            \n            \n              Muralee\n              S,\n            \n            \n              Penland\n              H,\n            \n            \n              Tampi\n              RR.\n            \n          \n          Catatonia: A review. Ann Clin Psychiatry. 2008;20(2):97-107. DOI: 10.1080\/10401230802017092"},{"issue":"2","key":"i2168-9709-14-3-215-b07","series-title":"Acta Psychiatr Scand","first-page":"129","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","unstructured":"Bush\n              G,\n            \n            \n              Fink\n              M,\n            \n            \n              Petrides\n              G,\n            \n            \n              Dowling\n              F,\n            \n            \n              Francis\n              A.\n            \n          \n          Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129-36. DOI: 10.1111\/j.1600-0447.1996.tb09814.x"},{"issue":"4","key":"i2168-9709-14-3-215-b08","series-title":"Eur Child Adolesc Psychiatry","first-page":"441","article-title":"Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia","volume":"24","author":"Raffin","year":"2015","unstructured":"Raffin\n              M,\n            \n            \n              Zugaj-Bensaou\n              L,\n            \n            \n              Bodeau\n              N,\n            \n            \n              Milhiet\n              V,\n            \n            \n              Laurent\n              C,\n            \n            \n              Cohen\n              D,\n            \n            et al.\n          \n          Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015;24(4):441-9. DOI: 10.1007\/s00787-014-0595-y"},{"key":"i2168-9709-14-3-215-b09","series-title":"Front Psychiatry","first-page":"637886","article-title":"Case report: A case of pediatric catatonia: Role of the lorazepam challenge test","volume":"12","author":"Ridgeway","year":"2021","unstructured":"Ridgeway\n              L,\n            \n            \n              Okoye\n              A,\n            \n            \n              McClelland\n              I,\n            \n            \n              Dhossche\n              D,\n            \n            \n              Kutay\n              D,\n            \n            \n              Loureiro\n              M.\n            \n          \n          Case report: A case of pediatric catatonia: Role of the lorazepam challenge test. Front Psychiatry. 2021;12:637886. DOI: 10.3389\/fpsyt.2021.637886"},{"key":"i2168-9709-14-3-215-b10","series-title":"Front Psychiatry","first-page":"674335","article-title":"Excited catatonia in autism spectrum disorder: A case series","volume":"12","author":"Burns","year":"2021","unstructured":"Burns\n              NK,\n            \n            \n              Grissett\n              K,\n            \n            \n              Macaluso\n              M,\n            \n            \n              Raza\n              M,\n            \n            \n              Gracious\n              B.\n            \n          \n          Excited catatonia in autism spectrum disorder: A case series. Front Psychiatry. 2021;12:674335. DOI: 10.3389\/fpsyt.2021.674335"},{"key":"i2168-9709-14-3-215-b11","series-title":"Neuropsychiatr Dis Treat","first-page":"931","article-title":"Medication management during electroconvulsant therapy","volume":"12","author":"Zolezzi","year":"2016","unstructured":"Zolezzi\n              M.\n            \n          \n          Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 2016;12:931-9. DOI: 10.2147\/NDT.S100908"},{"key":"i2168-9709-14-3-215-b12","series-title":"J Am Coll Clin Pharm","first-page":"1","article-title":"Role of board-certified psychiatric pharmacists in child and adolescent psychiatry","author":"Stutzman","year":"2023","unstructured":"Stutzman\n              DL,\n            \n            \n              Leiby\n              LE,\n            \n            \n              Temelie\n              A,\n            \n            \n              Maroney\n              MM,\n            \n            \n              Williams\n              AM,\n            \n            \n              Parmentier\n              BL,\n            \n            et al.\n          \n          Role of board-certified psychiatric pharmacists in child and adolescent psychiatry. J Am Coll Clin Pharm. 2023:1\u201011. DOI: 10.1002\/jac5.1880"},{"key":"i2168-9709-14-3-215-b13","series-title":"HCUP Statistical Brief #299 [Internet]","article-title":"Overview of hospital stays among children and adolescents, 2019","author":"Weiss","year":"2022","unstructured":"Weiss\n              AJ,\n            \n            \n              Liang\n              L,\n            \n            \n              Martin\n              K.\n            \n          \n          Overview of hospital stays among children and adolescents, 2019. HCUP Statistical Brief #299 [Internet]. Rockville, MD: Agency for Healthcare Research and Quality, Rockville, MD. 2022 [cited 2023 Nov]. Available from: www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb299-Hospital-Stays-Children-2019.pdf"},{"key":"i2168-9709-14-3-215-b14","series-title":"J ECT","first-page":"60","article-title":"Regulation of electroconvulsive therapy","volume":"34","author":"Livingston","year":"2018","unstructured":"Livingston\n              R,\n            \n            \n              Wu\n              C,\n            \n            \n              Mu\n              K,\n            \n            \n              Coffey\n              MJ.\n            \n          \n          Regulation of electroconvulsive therapy. J ECT2018;34:60-8. DOI: 10.1097\/YCT.0000000000000460"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/3\/article-p215.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/14\/3\/215\/3381142\/i2168-9709-14-3-215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/3\/article-p215.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/3\/article-p215.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:01:37Z","timestamp":1740268897000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/3\/article-p215.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":14,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2024.06.215","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}